Status and phase
Conditions
Treatments
About
This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
156 participants in 6 patient groups
Loading...
Central trial contact
Emily R Smith, ScD, MPH; Christopher R Sudfeld, ScD, ScM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal